ASA (500 μg/air pouch) |
TNF-α induced exudate (6 h) |
2.3 × 106 leukocytes/ pouch FVB mice |
18R HEPE |
[21] |
EPA (500 μg/ air pouch) |
Air pouch leukocyte |
Resolvin E1 |
IL-1β-treated |
HUVEC |
IL-1β (24 h) and ASA |
18R HEPE |
[21] |
Human HUVEC |
|
Serum-treated zymosan 100 ng/ mL |
Human PMN |
PMN 30 × 106, 30 min |
Resolvin E1 |
[21] |
ASA recombinant COX-2 EPA products |
STZ (100 ng/mL) |
Lipoxin A5
|
FMLP 10−7 M |
GM-CSF Human PMN |
PMN 30 × 106
|
Lipoxin A4
|
[205] |
200 pM rhGMCSF |
Lipoxin B4
|
90 minutes |
A23187 (20 min) |
Trout Macrophages |
10 × 106 cells, A23187 |
Lipoxin A4
|
[206] |
20 min, 18 °C |
Lipoxin A5
|
TNF-α (50 ng/mL) 24 h |
Human Microglia |
ASA, 30 min |
17R-HDHA |
[8] |
Hypoxia |
HUVEC |
ASA, TNF-α, IL-1β + Hypoxia |
17R-HDHA |
[8] |
DHA (20 μg/ 1 × 106) |
ASA |
Inflammatory exudates |
6 h, FVB mice |
17R-Resolvin D5 |
[8] |
Mouse ASA |
17R-Resolvin D3 |
Zymosan |
Human PMN |
PMN (50 × 106 cells/ ml) |
D series Resolvins |
[8] |
Zymosan 100 ng/mL |
17R HDHA (5μg/mL) |
IL-1β or |
Retinal ARPE-19 cells |
IL-1β (6 h) |
NPD1 |
[166] |
A23187 |
TLR-7 Agonist (R-848) |
Human monocytes |
10 × 106 cells + |
Resolvin D5 |
[207] |
R-848 (100 μM) |
Protectin D1 |
1 h, 37 °C |
|
Apoptotic PMN |
10 × 106 cells |
E series Resolvins |
[17] |
D series Resolvins |
Mouse apoptotic PMN |
M0 Macrophages |
Time course 120 min efferocytosis |
Lipoxin A4, Resolvin E1 |
[80] |
Protectin D1 |
ASA + EPA |
Human M0 Macrophages |
EPA (20μM) for 45 min |
Resolvin E1 |
[80] |
E. coli |
M2 human Macrophages |
5 × 106 M2 Macrophages |
Resolvin D5 |
[18] |
90 min, 37 °C |
sPLA2 Type V |
Microparticle |
Zymosan peritonitis (1 mg) exudates 48 h |
17-HDHA |
[191] |
14-HDHA |
E. coli (105 CFU) |
Infectious Leukocytes |
In vivo collected exudate 24 h |
Resolvin D3 |
[138] |
Exudate |
18-HEPE (5μg) |
Human PMN |
Hypoxia PMN plus |
Resolvin E1 |
[78] |
Zymosan (100 μg/mL) |
Resolvin E2 |
LPS/ FMLP |
GM-CSF Human Macrophages |
LPS (1μg/mL) 20 min |
Lipoxin A4
|
[208] |
+ FMLP (1μM) 10 min |
17-HDHA |
37 °C |
Zymosan peritonitis (1 mg) |
Eosinophils |
In vivo collected exudate 24 h |
Lipoxin A4
|
[209] |
Protectin D1 |
HMGB1+ C1q |
Human Monocytes |
HMGB1 (1μg/mL) |
Lipoxin A4
|
[20] |
C1q (25 μg/mL) |
Resolvin D1 |
6 h |
Resolvin D2 |
HMGB1 alone |
Human Monocytes |
HMGB1 (1μg/mL) |
Leukotriene B4
|
[20] |
Carbon monoxide (CO) + zymosan in vivo in mice |
Mouse Peritoneal Exudates |
250 ppm CO |
Resolvin E2 |
[210] |
0.1 mg/ zymosan |
Resolvin D1 |
Resolvin D2 |
Maresin 1 |
Zymosan peritonitis (1 mg) |
Human MCSF Macrophages |
Endogenous Maresin 1 |
Maresin 1 |
[15,175] |
Stereochemistry |
Physiologic Hypoxia (1 % oxygen) |
Human M2 Macrophages |
24 h hypoxia chamber |
RvE4 |
[85] |
D-Series Resolvins |
EPA (1 g) |
Human plasma collected (3 h) |
|
18-HEPE |
[77] |